Lyra Health, a Burlingame, CA-based developer of technology that allows patients to find the best available care for mental health conditions and substance abuse, raised $35m in Series A financing.
The round was led by Greylock Partners with participation from Venrock, Castlight Health, and new investors Providence Health & Services, Breyer Capital and Origin Capital Management.
The company intends to use the funds to make its technology available to employers, health plans, and health care providers starting with a select group of enterprise and health plan customers in the first quarter of 2016. It anticipates full commercial availability in 2017.
Founded earlier this year by CEO David Ebersman (formerly CFO at Facebook and Genentech); Chief Medical Officer Dena Bravata (formerly CMO & Head of Products at Castlight); and Venrock partners Bryan Roberts and Bob Kocher, Lyra Health provides technology that matches each patient with the best available mental health treatment based on the individual’s unique clinical needs and treatment preferences, evidence-based clinical guidelines, and understanding of provider capabilities.
The technology also assesses treatment outcomes over time to ensure that each patient is getting better and connects each patient with a care manager who provides support throughout the care journey.
The company’s team also includes Chief Data Scientist Daniella Perlroth and Chief Technology Officer Daniel Tunkelang.